|
||||||||
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Select Publications
Albain K et al. Concurrent (CAFT) versus sequential (CAF-T) chemohormonal therapy (cyclophosphamide, doxorubicin, 5-fluorouracil, tamoxifen) versus T alone for postmenopausal, node-positive, estrogen (ER) and/or progesterone (PgR) receptor positive
breast cancer: Mature outcomes and new biologic correlates on Phase III Intergroup trial 0100 (SWOG-8814). Breast Cancer Res Treat 2004;88(Suppl 1):A-37. No abstract available
Hayes DF et al. HER2 and response to paclitaxel in node-positive breast cancer. N Engl J Med 2007;357(15):1496-506. Abstract
Pinder MC et al. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 2007;25(25):3808-15. Abstract
Press MF et al. Topoisomerase II-alpha gene amplification as a predictor of responsiveness to anthracycline-containing chemotherapy in the Cancer International Research Group 006 clinical trial of trastuzumab (Herceptin) in the adjuvant setting. Poster. San Antonio Breast Cancer Symposium 2005;Abstract 1045.
Slamon D et al. BCIRG 006: 2nd interim analysis phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC
T) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (AC TH) with docetaxel, carboplatin and trastuzumab (TCH) in Her2neu positive early breast cancer patients. Presentation. San Antonio Breast Cancer Symposium 2006;Abstract 52.
Sledge G et al. Safety and efficacy of capecitabine (C) plus bevacizumab (B) as first-line in metastatic breast cancer. Proc ASCO 2007;Abstract 1013.
Theodoulou M et al. Phase I study of a novel capecitabine schedule based on Norton-Simon mathematical modeling. Proc ASCO 2007;Abstract 1045.
Traina TA et al. Preclinical testing of a novel regimen of capecitabine (C) in combination with bevacizumab (B) and trastuzumab (T) in a breast cancer xenograft model. Proc ASCO 2007;Abstract 1049.
Yap YS et al. Clinical efficacy of capecitabine as first-line chemotherapy in metastatic breast cancer — How low can you go? Breast 2007;16(4):420-4. Abstract
 |
 |
EDITOR'S NOTE
Another perspective on metastatic breast cancer
Neil Love, MD
- Select publications
INTERVIEWS
Larry Norton, MD
- Select publications
John Mackey, MD
- Select publications
Charles E Geyer Jr, MD
- Select publications
Roundtable Discussions
- Select publications
Breast Cancer Update:
A CME Audio Series and Activity
 |
 |
 |
 |
 |
